Derma Sciences, Inc. Common Stock (DE)
DSCI
DSCI was delisted on the 23rd of February, 2017.
61 hedge funds and large institutions have $78M invested in Derma Sciences, Inc. Common Stock (DE) in 2016 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 20 reducing their positions, and 3 closing their positions.
267% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 3
94% more call options, than puts
Call options by funds: $99K | Put options by funds: $51K
15% more funds holding
Funds holding: 53 → 61 (+8)
12% more capital invested
Capital invested by funds: $69.6M → $78M (+$8.43M)
20% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
+$467K |
| 2 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
+$327K |
| 3 |
Renaissance Technologies
New York
|
+$272K |
| 4 |
UBS AM
Chicago,
Illinois
|
+$173K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$137K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$2.01M |
| 2 |
D.E. Shaw & Co
New York
|
-$1.06M |
| 3 |
SM
Senvest Management
New York
|
-$900K |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$865K |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$431K |
DSCI Hedge Fund Activity: Q3 2016 in Review
61 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Derma Sciences, Inc. Common Stock (DE) (DSCI) for Q3 2016, worth a combined $78M — up 12% from $69.6M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new DSCI positions and 3 closed out — a net gain of 8 holders — while 16 added to existing stakes and 20 trimmed.
The largest buyer was Royce & Associates, adding an estimated $467K. The largest seller was Perceptive Advisors, cutting an estimated $2.01M.
- 61 institutional investors held Derma Sciences, Inc. Common Stock (DE) (DSCI) as of Q3 2016, up from 53 in Q2 2016.
- Funds reported $78M of Derma Sciences, Inc. Common Stock (DE) stock for Q3 2016, up 12% quarter-over-quarter.
- 11 funds opened new Derma Sciences, Inc. Common Stock (DE) positions in Q3 2016 and 3 closed out, a net change of +8 holders.
- The largest Derma Sciences, Inc. Common Stock (DE) buyer in Q3 2016 was Royce & Associates, an estimated $467K added.
- The largest Derma Sciences, Inc. Common Stock (DE) seller in Q3 2016 was Perceptive Advisors, an estimated $2.01M sold.
Based on aggregated 13F filings for Q3 2016.